Lapatinib CAS 231277-92-2

Product Name: Lapatinib
Synonyms: lapatinib;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;Lapatinib(TINIBS);Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine;4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline;GSK572016
CAS: 231277-92-2
MF: C29H26ClFN4O4S
MW: 581.0575432
EINECS: 1806241-263-5
Product Categories: -;Molecular Targeted Antineoplastic;anti-neoplastic;Pharmaceutical intermediate;APIs;API;Lapatinib;Anti-cancer&immunity;Inhibitors

Density: 1.381 g/cm3
Boiling Point: 750.7ºC at 760 mmHg
Flash Point: 407.8ºC
Refractive Index: 1.645
Vapor Pressure: 0mmHg at 25°C

Purity: 98%
Appearance: white to light yellow solid
Package: aluminum foil bag,25kg/drum or as your special request
Uses: antineoplastic, tyrosine kinase inhibitor
An antineoplastic agent used in breast cancer research

Product Categories : Fine Chemical